Wells Fargo & Company Forecasts Strong Price Appreciation for Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Given New $45.00 Price Target at Wells Fargo & Company

Kiniksa Pharmaceuticals International (NASDAQ:KNSA – Free Report) had its price target hoisted by Wells Fargo & Company from $42.00 to $45.00 in a research note issued to investors on Thursday,Benzinga reports. The brokerage currently has an overweight rating on the stock. KNSA has been the topic of several other reports. Wedbush reiterated an “outperform” rating and issued a $36.00 price target on shares of Kiniksa Pharmaceuticals International…

Wells Fargo & Company Forecasts Strong Price Appreciation for Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock

Wells Fargo & Company upped their price target on shares of Kiniksa Pharmaceuticals International from $42.00 to $45.00 and gave the stock an "overweight" rating in a report on Thursday.